Literature DB >> 18596054

Translumbar treatment of type II endoleaks after endovascular repair of abdominal aortic aneurysm.

Michael Gorlitzer1, Gerard Mertikian, Hubert Trnka, Alexander Froeschl, Johann Meinhart, Gabriel Weiss, Martin Grabenwoeger, Thomas Rand.   

Abstract

The modality of treatment and the appropriate time point to treat type II endoleaks after endovascular repair of abdominal aortic aneurysms (EVAR) remain controversial issues. The purpose of the present study was to assess the efficacy of translumbar embolization of type II endoleaks after endovascular repair of aortic aneurysm repair. Eighty-four consecutive patients after EVAR were analyzed for the onset of type II endoleaks. Of these, five patients had experienced translumbar embolization after ineffective intraartrial approach to exclude the endoleak. A combination of several liquid embolic agents was used as sealant. Post-procedural contrast-enhanced ultrasound (CEUS) was used to document the outcome of the embolization. Translumbar embolization was successful in four patients. Complete sealing of the nidus was seen on CEUS 24 h after the procedure. In one patient with a duplication of the inferior vena cava, the procedure was aborted because an additional type Ib endoleak was found. The procedure was well tolerated by all patients. The translumbar approach to treat growing aneurysm sacs in patients with persistent type II endoleaks is safe and well tolerated. The immediate post-interventional outcome as documented on CEUS is promising. Long-term follow-ups are yet to be performed.

Entities:  

Mesh:

Year:  2008        PMID: 18596054     DOI: 10.1510/icvts.2008.178624

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  7 in total

Review 1.  Use of cyanoacrylate adhesives in general surgery.

Authors:  David García Cerdá; Antonio Martín Ballester; Alicia Aliena-Valero; Anna Carabén-Redaño; José M Lloris
Journal:  Surg Today       Date:  2014-10-25       Impact factor: 2.549

2.  Clinical significance of endoleaks characterized by computed tomography during aortography performed immediately after endovascular abdominal aortic aneurysm repair: prediction of persistent endoleak.

Authors:  Motoki Nakai; Hirotatsu Sato; Morio Sato; Yuko Tanba; Yasutaka Noda; Akira Ikoma; Hiroki Sanda; Kohei Nakata; Hiroki Minamiguchi; Nobuyuki Kawai; Tetsuo Sonomura; Kazushi Kishi; Yosiharu Nishimura; Yoshitaka Okamura
Journal:  Jpn J Radiol       Date:  2012-10-10       Impact factor: 2.374

3.  Evaluation and treatment of suspected type II endoleaks in patients with enlarging abdominal aortic aneurysms.

Authors:  Brian Funaki; Nour Birouti; Steven M Zangan; Thuong G Van Ha; Jonathan M Lorenz; Rakesh Navuluri; Christopher L Skelly; Jeffrey A Leef
Journal:  J Vasc Interv Radiol       Date:  2012-05-19       Impact factor: 3.464

4.  Successful Percutaneous Coil Embolization of a Ruptured Internal Iliac Artery Aneurysm Remnant after Abdominal Aortic Aneurysm Repair via the Deep Iliac Circumflex Artery.

Authors:  Takahiro Ohmine; Kazuomi Iwasa; Terutoshi Yamaoka
Journal:  Ann Vasc Dis       Date:  2014-02-04

5.  Preoperative Coil Embolization to Aortic Branched Vessels for Prevention of Aneurysmal Sac Enlargement Following EVAR: Early Clinical Result.

Authors:  Genta Chikazawa; Hidenori Yoshitaka; Arudo Hiraoka; Koyu Tanaka; Norio Mouri; Kentaro Tamura; Toshinori Totsugawa; Atsuhisa Ishida; Taichi Sakaguchi
Journal:  Ann Vasc Dis       Date:  2013-05-10

6.  Transcaval embolization as an alternative technique for the treatment of type II endoleak after endovascular aortic aneurysm repair.

Authors:  Salvatore T Scali; Adrian Vlada; Catherine K Chang; Adam W Beck
Journal:  J Vasc Surg       Date:  2013-01-09       Impact factor: 4.268

7.  Ischemic Colitis Following Transarterial Embolization for Type 2 Endoleak of EVAR: Report of a Case.

Authors:  Toshiro Ito; Yoshihiko Kurimoto; Nobuyoshi Kawaharada; Tetsuya Koyanagi; Toshiyuki Maeda; Yohsuke Yanase; Junji Nakazawa; Naoki Hirokawa; Tetsuya Higami
Journal:  Ann Vasc Dis       Date:  2012-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.